Skip to main content

Market Overview

Benzinga's Top Upgrades, Downgrades For November 15, 2017

Share:

Top Upgrades

  • Analysts at JP Morgan upgraded Boot Barn Holdings Inc (NYSE: BOOT) from Neutral to Overweight. Boot Barn shares fell 0.68 percent to close at $11.69 on Tuesday.
  • Jefferies upgraded YY Inc (ADR) (NASDAQ: YY) from Hold to Buy. YY shares rose 4.23 percent to $93.00 in pre-market trading.
  • JPMorgan upgraded Dicks Sporting Goods Inc (NYSE: DKS) from Neutral to Overweight. Dick's Sporting shares rose 2.07 percent to $26.12 in pre-market trading.
  • Raymond James upgraded Alaska Air Group, Inc. (NYSE: ALK) from Outperform to Strong Buy. Alaska Air shares fell 0.04 percent to close at $61.68 on Tuesday.
  • Piper Jaffray upgraded Sangamo Therapeutics Inc (NASDAQ: SGMO) from Neutral to Overweight. Sangamo Therapeutics shares closed at $12.90 on Tuesday.
  • Stephens upgraded Ingredion Inc (NYSE: INGR) from Equal Weight to Overweight. Ingredion shares rose 1.16 percent to close at $130.63 on Tuesday.
  • Argus upgraded Tyson Foods, Inc. (NYSE: TSN) from Hold to Buy. Tyson Foods shares rose 0.18 percent to $76.21 in pre-market trading.
  • Leerink Swann upgraded TESARO Inc (NASDAQ: TSRO) from Market Perform to Outperform. Tesaro shares rose 2.04 percent to $88.50 in pre-market trading.
  • Noble Financial upgraded Engility Holdings, Inc. (NYSE: EGL) from Hold to Buy. Engility Holdings shares declined 0.89 percent to close at $26.79 on Tuesday.


Top Downgrades

  • JMP Securities downgraded Snap Inc (NYSE: SNAP) from Market Outperform to Market Perform. Snap shares fell 1.35 percent to $12.40 in pre-market trading.
  • Raymond James downgraded BroadSoft Inc (NASDAQ: BSFT) from Outperform to Market Perform. Broadsoft shares fell 0.09 percent to close at $54.65 on Tuesday.
  • Jefferies downgraded Smart Sand Inc (NASDAQ: SND) from Buy to Hold. Smart Sand shares declined 0.82 percent to close at $8.42 on Tuesday.
  • William Blair downgraded IHS Markit Ltd (NASDAQ: INFO) from Outperform to Market Perform. IHS Markit shares gained 2.09 percent to close at $43.89 on Tuesday.
  • BMO Capital downgraded TreeHouse Foods Inc. (NYSE: THS) from Outperform to Market Perform. TreeHouse Foods shares dropped 1.21 percent to $41.49 in pre-market trading.
  • Analysts at Bank of America downgraded MACOM Technology Solutions Holdings Inc (NASDAQ: MTSI) from Neutral to Underperform. MACOM Technology shares declined 13.96 percent to $31.50 in pre-market trading.
  • Argus downgraded Cardinal Health Inc (NYSE: CAH) from Buy to Hold. Cardinal Health shares fell 0.56 percent to $56.75 in pre-market trading.
  • Analysts at UBS downgraded Marathon Petroleum Corp (NYSE: MPC) from Buy to Neutral. Marathon Petroleum shares rose 1.06 percent to close at $62.87 on Tuesday.


Top Initiations

  • BMO Capital initiated coverage on Fortive Corp (NYSE: FTV) with an Outperform rating. The price target for Fortive set to $82. Fortive shares closed at $72.67 on Tuesday.
  • SunTrust Robinson Humphrey initiated coverage on AnaptysBio Inc (NASDAQ: ANAB) with a Buy rating. The price target for AnaptysBio set to $115. AnaptysBio shares closed at $71.08 on Tuesday.
  • Analysts at HSBC initiated coverage on Arcos Dorados Holding Inc (NYSE: ARCO) with a Buy rating. The price target for Arcos Dorados set to $12. Arcos Dorados shares closed at $9.70 on Tuesday.
  • Imperial Capital initiated coverage on Extraction Oil & Gas Inc (NASDAQ: XOG) with an Outperform rating. The price target for Extraction Oil & Gas is set to $20. Extraction Oil & Gas shares closed at $14.32 on Tuesday.
  • Analysts at Stifel Nicolaus initiated coverage on Qudian Inc - ADR (NYSE: QD) with a Buy rating. The price target for Qudian is set to $35. Qudian shares closed at $25.16 on Tuesday.
  • H.C. Wainwright assumed coverage on Karyopharm Therapeutics Inc (NASDAQ: KPTI) with a Buy rating. The price target for Karyopharm Therapeutics is set to $23. Karyopharm Therapeutics shares closed at $10.54 on Tuesday.
  • Analysts at BMO Capital initiated coverage on VBI Vaccines, Inc. (NASDAQ: VBIV) with an Outperform rating. The price target for VBI Vaccines is set to $11. VBI Vaccines shares closed at $4.17 on Tuesday.
 

Related Articles (ALK + ANAB)

View Comments and Join the Discussion!

Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

Latest Ratings

StockFirmActionPT
SAMEvercore ISI GroupMaintains1,500.0
SEAutonomous ResearchInitiates Coverage On378.0
ALHCMorgan StanleyInitiates Coverage On36.0
ALHCRaymond JamesInitiates Coverage On30.0
HAEMorgan StanleyDowngrades83.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com